Vascular oxidative stress upregulates angiotensin II type i receptors via mechanisms involving nuclear factor kappa B

Clinical and Experimental Hypertension

Volumn 36, Issue 6, 2014, Pages 367-373

  Bhatt, Siddhartha R ^a   Lokhandwala, Mustafa F ^a   Banday, Anees Ahmad ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

AT1 receptors; NF B; Oxidative stress; PDTC; Vasoconstriction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CATALASE; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR RELA; BUTHIONINE SULFOXIMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDIZING AGENT; PROLINE; PROLINEDITHIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; VASOCONSTRICTION; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ANIMALS; AORTA; BUTHIONINE SULFOXIMINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; OXIDANTS; OXIDATIVE STRESS; PROLINE; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; THIOCARBAMATES; UP-REGULATION; VASOCONSTRICTION;

EID: 84907031245     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2014.943402     Document Type: Article

References (37)

1. Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008;31:S181-4.
2. Grossman E. Does increased oxidative stress cause hypertension?. Diabetes Care 2008;31:S185-9.
3. Nickenig G, Harrison DG. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation 2002;105:393-6.
4. Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004;44:381-6.
5. Fukui T, Ishizaka N, Rajagopalan S, et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997;80:45-51.
6. Kerr S, Brosnan MJ, McIntyre M, et al. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 1999;33:1353-8.
7. Tanito M, Nakamura H, Kwon YW, et al. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 2004;6:89-97.
8. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004;44:248-52.
9. Jackson EK, Herzer WA, Vyas SJ, Kost Jr CK. Angiotensin II-induced renal vasoconstriction in genetic hypertension. J Pharmacol Exp Therap 1999;291:329-34.
10. Tahvanainen A, Taurio J, Maki-Jouppi J, et al. Increased wall tension in response to vasoconstrictors in isolated mesenteric arterial rings from patients with high blood pressure. Basic Clin Pharmacol Toxicol 2006;99:440-9.
11. Lockette W, Otsuka Y, Carretero O. The loss of endotheliumdependent vascular relaxation in hypertension. Hypertension 1986; 8:II61-6.
12. Morawietz H, Weber M, Rueckschloss U, et al. Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension. Biochem Biophys Res Commun 2001;285:1130-5.
13. Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol 2000;55:221-32.
14. Levy BI. The potential role of angiotensin II in the vasculature. J Hum Hypertension 1998;12:283-7.
15. Nickenig G, Strehlow K, Roeling J, et al. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 1998;31: 1272-7.
16. Reja V, Goodchild AK, Phillips JK, Pilowsky PM. Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol 2006;33: 690-5.
17. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 2003;30:860-6
18. Banday AA, Fazili FR, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factor-kappaB and protein kinase C. J Am Soc Nephrol 2007;18:1446-57.
19. Lavrovsky Y, Chatterjee B, Clark RA, Roy AK. Role of redoxregulated transcription factors in inflammation, aging and agerelated diseases. Exp Gerontol 2000;35:521-32.
20. Toledano MB, Leonard WJ. Modulation of transcription factor NFkappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 1991;88:4328-32.
21. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-20.
22. Barchowsky A, Munro SR, Morana SJ, et al. Oxidant-sensitive and phosphorylation-dependent activation of NF-kappa B and AP-1 in endothelial cells. Am J Physiol 1995;269:L829-36.
23. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18:2195-224.
24. Heinemeyer T, Wingender E, Reuter I, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998;26:362-7.
25. Marwaha A, Banday AA, Lokhandwala MF. Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 2004;286:F451-7.
26. Shacter E, Williams JA, Lim M, Levine RL. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med 1994;17: 429-37.
27. Asghar M, Chillar A, Lokhandwala MF. Renal proximal tubules from old Fischer 344 rats grow into epithelial cells in cultures and exhibit increased oxidative stress and reduced D1 receptor function. Am J Physiol Cell Physiol 2008;295:C1326-31.
28. Rush JW, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med (Maywood, NJ) 2007;232:814-22.
29. Liu D, Gao L, Roy SK, et al. Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ Res 2008;103:186-93.
30. Mitra AK, Gao L, Zucker IH. Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons. Am J Physiol Cell Physiol 2010;299:C561-9.
31. Akpaffiong MJ, Taylor AA. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am J Hypertens 1998;11:1450-60.
32. Banday AA, Muhammad AB, Fazili FR, Lokhandwala M. Mechanisms of oxidative stress-induced increase in salt sensitivity and development of hypertension in Sprague-Dawley rats. Hypertension 2007;49:664-71.
33. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ. Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) 1991;81:739-42.
34. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, et al. Antioxidantrich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003;41:341-6.
35. Elks CM, Mariappan N, Haque M, et al. Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Renal Physiol 2009;296:F298-305.
36. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, et al. Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 2005; 315:51-7.
37. Cowling RT, Gurantz D, Peng J, et al. Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta. J Biol Chem 2002;277: 5719-24.